-
1
-
-
0028211185
-
In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells
-
BLAT, C., VILLAUDY, J. and BINOUX, M., In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells. J. clin. Invest., 93, 2286-2290 (1994).
-
(1994)
J. Clin. Invest.
, vol.93
, pp. 2286-2290
-
-
Blat, C.1
Villaudy, J.2
Binoux, M.3
-
2
-
-
0024539364
-
Effect of tamoxifen on plasma insulin-like growth factor I in patients with breast cancer
-
COLLETTI, R.B., ROBERTS, J.D., DEVLIN, J.T. and COPELAND, K.C., Effect of tamoxifen on plasma insulin-like growth factor I in patients with breast cancer. Cancer Res., 49, 1882-1884 (1989).
-
(1989)
Cancer Res.
, vol.49
, pp. 1882-1884
-
-
Colletti, R.B.1
Roberts, J.D.2
Devlin, J.T.3
Copeland, K.C.4
-
3
-
-
0026223775
-
Insulin-like growth factor binding proteins (IGFBPs) in acromegaly
-
COULSON, V.J., WASS, J.A.H., ABDULLA, A.F., COTTLRILL, A.M. and HOLLY, J.M.P., Insulin-like growth factor binding proteins (IGFBPs) in acromegaly. Growth Reg., 1, 119-124 (1991).
-
(1991)
Growth Reg.
, vol.1
, pp. 119-124
-
-
Coulson, V.J.1
Wass, J.A.H.2
Abdulla, A.F.3
Cottlrill, A.M.4
Holly, J.M.P.5
-
4
-
-
0027292076
-
Two site- Specific radioimmunoassays which demonstrate the presence of proteolytically modified insulin-like growth factor-binding protein-3 in circulation
-
CWYFAN-HUGHES, S.C., WASS. J.A.H. and HOLLY, J.M.P., Two site- specific radioimmunoassays which demonstrate the presence of proteolytically modified insulin-like growth factor-binding protein-3 in circulation. J. Endocrinol., 137, 321-328 (1993).
-
(1993)
J. Endocrinol.
, vol.137
, pp. 321-328
-
-
Cwyfan-Hughes, S.C.1
Wass, J.A.H.2
Holly, J.M.P.3
-
5
-
-
0025144244
-
Regulation of serum insulin-like growth factor-I (IGF-I) and IGF binding proteins during rat pregnancy
-
DAVENPORT, M.L., CLEMMONS, D.R., MILES, M.V., CAMACHO-HUBNER, C., D'ERCOLE, A.J. and UNDERWOOD, L.E., Regulation of serum insulin-like growth factor-I (IGF-I) and IGF binding proteins during rat pregnancy. Endocrinology. 127, 1278-1286 (1990).
-
(1990)
Endocrinology
, vol.127
, pp. 1278-1286
-
-
Davenport, M.L.1
Clemmons, D.R.2
Miles, M.V.3
Camacho-Hubner, C.4
D'Ercole, A.J.5
Underwood, L.E.6
-
6
-
-
0029938078
-
Effects of treatment with megestrol acetate, aminoglutethimide or formestane on insulin-like growth factor (IGF)-I and -II, IGF-binding proteins and IGFBP-3 protease status in patients with advanced breast cancer
-
FROST, V.J., HELLE, S.I., LØNNING, P.E., VAN DER STAPPEN, J.W.J. and HOLLY, J.M.P., Effects of treatment with megestrol acetate, aminoglutethimide or formestane on insulin-like growth factor (IGF)-I and -II, IGF-binding proteins and IGFBP-3 protease status in patients with advanced breast cancer. J. clin. endocrinol. Metab., 81, 2216-2221 (1996).
-
(1996)
J. Clin. Endocrinol. Metab.
, vol.81
, pp. 2216-2221
-
-
Frost, V.J.1
Helle, S.I.2
LØnning, P.E.3
Van der Stappen, J.W.J.4
Holly, J.M.P.5
-
7
-
-
0029124925
-
Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin dependent diabetic patients compared to that in healthy subjects
-
HILDING, A., BRISMAR, K., DEGERBLAD, M., THOREN, M. and HALL, K., Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin dependent diabetic patients compared to that in healthy subjects. J. clin. endocrinol. Metab., 80, 2646-2652 (1995).
-
(1995)
J. Clin. Endocrinol. Metab.
, vol.80
, pp. 2646-2652
-
-
Hilding, A.1
Brismar, K.2
Degerblad, M.3
Thoren, M.4
Hall, K.5
-
8
-
-
0027287960
-
Proteases acting on IGFBPs: Their occurrence and physiological significance
-
HOLLY, J.M.P., CLAFFEY, D.C.P., CWYFAN-HUGHES, S.C., FROST, V.J. and YATEMAN, M.E., Proteases acting on IGFBPs: their occurrence and physiological significance. Growth Reg., 3, 58-61 (1993).
-
(1993)
Growth Reg.
, vol.3
, pp. 58-61
-
-
Holly, J.M.P.1
Claffey, D.C.P.2
Cwyfan-Hughes, S.C.3
Frost, V.J.4
Yateman, M.E.5
-
9
-
-
0025074841
-
Evidence of enzymatic degradation of insulin-like growth factor-binding proteins in the 150K complex during pregnancy
-
HOSSENLOPP, P., SEGOVIA, B., LASSARRE, C., ROOHANI, M., BREDON, M. and BINOUX, M., Evidence of enzymatic degradation of insulin-like growth factor-binding proteins in the 150K complex during pregnancy. J clin. endocrinol Metab., 71, 797-805 (1990).
-
(1990)
J Clin. Endocrinol Metab.
, vol.71
, pp. 797-805
-
-
Hossenlopp, P.1
Segovia, B.2
Lassarre, C.3
Roohani, M.4
Bredon, M.5
Binoux, M.6
-
10
-
-
0027174116
-
In vivo inhibition of insulin-like growth factor I gene expression by tamoxifen
-
HUYNH, H.T., TETENES, E., WALLACE, L. and POLLAK, M., In vivo inhibition of insulin-like growth factor I gene expression by tamoxifen. Cancer Res., 53, 1727-1730 (1993).
-
(1993)
Cancer Res.
, vol.53
, pp. 1727-1730
-
-
Huynh, H.T.1
Tetenes, E.2
Wallace, L.3
Pollak, M.4
-
11
-
-
0028958031
-
Insulin-like growth factors and their binding proteins: Biological actions
-
JONES, J.I. and CLEMMONS, D.R., Insulin-like growth factors and their binding proteins: biological actions. Endocrine Rev., 16, 3-34 (1995).
-
(1995)
Endocrine Rev.
, vol.16
, pp. 3-34
-
-
Jones, J.I.1
Clemmons, D.R.2
-
12
-
-
0023710584
-
Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17β-estradiol
-
KAREY, K.P. and SIRBASKU, D.A., Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17β-estradiol. Cancer Res., 48, 4083-4092 (1988).
-
(1988)
Cancer Res.
, vol.48
, pp. 4083-4092
-
-
Karey, K.P.1
Sirbasku, D.A.2
-
13
-
-
0028342709
-
Plasma insulin-like growth factor I and its binding protein I and 3 in postmenopausal patients with breast cancer receiving long term tamoxifen
-
LAHTI, E.I., KNIP, M. and LAATIKAINEN, T.J., Plasma insulin-like growth factor I and its binding protein I and 3 in postmenopausal patients with breast cancer receiving long term tamoxifen. Cancer, 74, 618-624 (1994).
-
(1994)
Cancer
, vol.74
, pp. 618-624
-
-
Lahti, E.I.1
Knip, M.2
Laatikainen, T.J.3
-
14
-
-
0028354529
-
Insulin-like growth factor binding protein-3 is functionally altered in pregnancy plasma
-
LASSARRE, C. and BINOUX, M., Insulin-like growth factor binding protein-3 is functionally altered in pregnancy plasma. Endocrinology, 134, 1254-1262 (1994).
-
(1994)
Endocrinology
, vol.134
, pp. 1254-1262
-
-
Lassarre, C.1
Binoux, M.2
-
15
-
-
0026779758
-
Influence of tamoxifen on plasma levels of insulin-like growth factor I and insulin-like growth factor binding protein 1 in breast cancer patients
-
LØNNING, P.E., HAU., K., AAKVAAG, A. and LIEN, E.A., Influence of tamoxifen on plasma levels of insulin-like growth factor I and insulin-like growth factor binding protein 1 in breast cancer patients. Cancer Res., 52, 4719-4723 (1992a).
-
(1992)
Cancer Res.
, vol.52
, pp. 4719-4723
-
-
LØnning, P.E.1
Hau, K.2
Aakvaag, A.3
Lien, E.A.4
-
16
-
-
0026585136
-
Clinical pharmacokinetics of endocrine agents used in advanced breast cancer
-
LØNNING, P.E., LIEN, E.A., LUNDGREN, S. and KVINNSLAND, S., Clinical pharmacokinetics of endocrine agents used in advanced breast cancer. Clin. Pharmacokinet., 22, 327-358 (19926).
-
(1992)
Clin. Pharmacokinet.
, vol.22
, pp. 327-358
-
-
LØnning, P.E.1
Lien, E.A.2
Lundgren, S.3
Kvinnsland, S.4
-
17
-
-
0025611672
-
Effect of tamoxifen on serum insulin-like growth factor I levels in stage I breast cancer patients
-
POLLAK, M, CONSTANTINO, J., POLYCHRONAKOS, C., BLAUER, S.-A., GUYDA, H., REDMOND, C., FISHER, B. and MARGOLESE, R., Effect of tamoxifen on serum insulin-like growth factor I levels in stage I breast cancer patients. J. nat. Cancer Inst., 82, 1693-1697 (1990).
-
(1990)
J. Nat. Cancer Inst.
, vol.82
, pp. 1693-1697
-
-
Pollak, M.1
Constantino, J.2
Polychronakos, C.3
Blauer, S.-A.4
Guyda, H.5
Redmond, C.6
Fisher, B.7
Margolese, R.8
-
18
-
-
0026806159
-
The effect of endocrine therapy with medroxyprogesterone acetate, 4-hydroxyandrostenedione or tamoxifen on plasma concentrations of insulin-like growth factor (IGF)-I, IGF-II and IGFBP-1 in women with advanced breast cancer
-
REED, M.J., CHRISTODOULIDES, A., KOISTINEN, R., SÄPPELÄ, M., TEALE, J.D. and GHILCHIK, M.W., The effect of endocrine therapy with medroxyprogesterone acetate, 4-hydroxyandrostenedione or tamoxifen on plasma concentrations of insulin-like growth factor (IGF)-I, IGF-II and IGFBP-1 in women with advanced breast cancer. Int. J. Cancer, 52, 208-212 (1992).
-
(1992)
Int. J. Cancer
, vol.52
, pp. 208-212
-
-
Reed, M.J.1
Christodoulides, A.2
Koistinen, R.3
Säppelä, M.4
Teale, J.D.5
Ghilchik, M.W.6
-
19
-
-
0028604497
-
Immunoreactive proinsulin-like growth factor-II in healthy subjects, patients with growth hormone deficiency, and patients with type 1 diabetes: Effects of insulin-like growth factor-I and insulin
-
TALLY, M., ERIKSSON, U., THORÉN, M., BRISMAR, K. and HALL, K., Immunoreactive proinsulin-like growth factor-II in healthy subjects, patients with growth hormone deficiency, and patients with type 1 diabetes: effects of insulin-like growth factor-I and insulin. J. clin. endocrinol. Metab., 79, 1576-1581 (1994).
-
(1994)
J. Clin. Endocrinol. Metab.
, vol.79
, pp. 1576-1581
-
-
Tally, M.1
Eriksson, U.2
Thorén, M.3
Brismar, K.4
Hall, K.5
-
20
-
-
0026728537
-
Tamoxifen attenuates pulsatile growth hormone secretion: Mediation in part by somatostatin
-
TANNENBAUM, G.S., GURD, W., LAPOINTE, M. and POLLAK, M., Tamoxifen attenuates pulsatile growth hormone secretion: mediation in part by somatostatin. Endocrinology, 130, 3395-3401 (1992).
-
(1992)
Endocrinology
, vol.130
, pp. 3395-3401
-
-
Tannenbaum, G.S.1
Gurd, W.2
Lapointe, M.3
Pollak, M.4
-
21
-
-
0027104634
-
Can "big" insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia?
-
ZAPF, J., FUTO, E., PETER, M. and FROESCH, E.R., Can "big" insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia? J. clin. Invest., 90, 2574-2584 (1992).
-
(1992)
J. Clin. Invest.
, vol.90
, pp. 2574-2584
-
-
Zapf, J.1
Futo, E.2
Peter, M.3
Froesch, E.R.4
|